Invest with Purpose

Essential News

Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities

Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities

  • New manufacturing capacity allows Establishment Labs to provide over half the current world demand for breast implants and supports upcoming launches in China and the U.S.
  • Global Learning Center expands training in next generation technologies
  • Establishment Labs also publishes 2022 Sustainability Review
Alajuela, Costa Rica, July 19, 2023. Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the grand opening of the Sulàyöm Innovation Campus in Coyol Free Zone, Costa Rica.

The Sulàyöm Campus will support Establishment Labs’ continued global growth with additional capacity and capabilities in manufacturing, R&D, digital media, training, and medical education. The first phase of the project, which opens today, includes approximately 100,000 square feet of manufacturing, medical, research, and office space. The added manufacturing more than doubles Establishment Labs’ capacity, allowing the company to provide over half the current world demand for breast implants.

“To the Bribri, an indigenous tribe in Costa Rica, the Sulàyöm mountain is regarded as the center of all creation. We chose to name our innovation campus Sulàyöm as a reminder of our heritage and of our unwavering commitment to women around the world,” said Juan José Chacón-Quirós, CEO and Founder of Establishment Labs. “Today, on the fifth anniversary of Establishment Labs’ public listing, we are scaling-up our company to support the growing demand for our products globally, including them being made available in the U.S. and China; the creation of a new category with Mia Femtech; and our commitment to expand access globally to high quality breast reconstruction.” 

The new facilities also include advanced R&D labs, new media production and broadcasting studios, executive offices and meeting facilities, and a Global Learning Center, which includes a surgical theatre and procedure rooms for medical education and training. The campus includes an additional 45,000 square feet of space that can be used to further expand manufacturing or other capabilities. The state-of-the-art facility is designed to be carbon neutral and uses sustainable materials and other green design elements and standards.

“Our new research labs will add to our technology and product development programs, and we are adding significant new capabilities in media and medical education,” Mr. Chacón-Quirós continued. “The campus also underscores our commitment to our communities by adding up to 1,000 new jobs over the next several years and continuing our traditions of sustainability. Our goal was to create a heart of creation and innovation, where our employees, healthcare professionals, partners, and consumers from all over the world can connect. This is what Sulàyöm means to Establishment Labs.”

Marianela Urgelles, CINDE's Managing Director mentioned "Establishment Labs is proud of its history, its development and its present, exporting innovation to more than 85 countries. This innovation center demonstrates the growth of the company and its impact in creating solutions that improve women's health. This company is promoting changes, design and science applications that place Costa Rica on the world map of Research and Development. From CINDE and with our experience, we reiterate that this project shows the transformation that the country is undergoing in the face of industry 4.0, where technology also converges at the hands of highly trained talent and that as a nation we must continue providing capacities that fit global changes."

The opening ceremony included a Discovery Session showcasing Establishment Labs innovations in science, technology, and product development. Establishment Labs also announced the publication of its 2022 Sustainability Review. The Sustainability Review is published annually and provides an assessment of the Company’s efforts in support of environmental and social issues in its communities. The current and previous editions of the annual review can be found on the company’s website at:

About Establishment Labs

Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The over three million Motiva® devices Establishment Labs has delivered to plastic and reconstructive surgeons since 2010 have created a new standard for safety and patient satisfaction in the over 85 countries in which they are available. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and it is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Mia Femtech™, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2016 and FDA 21 CFR 820 under the MDSAP program. In 2018, the Company received an investigational device exemption (IDE) from the FDA for Motiva Implants® and began a clinical trial to support regulatory approval in the United States. Please visit our website for additional information at